Regenerative Medicine Market Forecast To 2016-2028

Regenerative Medicine Market is projected to register high demand during the forecast period with increasing demand from major end-use industries such as oncology, cardiovascular, musculoskeletal, dermatology, ophthalmology, neurology, and wound healing during the forecast period. The process of replacing or regenerating human cells, tissues or organs to restore or establish normal functioning is known as regenerative medicine. These regenerative medicines are believed to have the potential to heal or replace tissues and organs damaged by diseases, age, or trauma, as well as to correct congenital defects.

The rapidly developing stem cell technology plays a vital role in regenerative medicine due to reasons such as its ability to serve the disciplines of nanotechnology, developmental cell biology, tissue engineering, cellular therapeutics, chemical biology, and gene therapy. Stem cells make the replacing of cells and tissues possible, which help in treating various issues related to health some of which are Parkinson’s disease, arthritis, spinal cord injury, etc. Increased use of stem cell technologies for the treatment of diseases has driven its rate of adoption.

The major factor driving the regenerative medicine market is technological advancements related to stem cell technology, biologics, tissue engineering, and biomaterials. There have been recent advancements in regenerative medicine, 3D bioprinting, and stem cell treatments for heart repair and vision loss.

Segment AnalysisBased on the product, the cell therapy segment is expected to account for a considerable share of the market due to factors such as its ability to restore organs and tissues. Moreover, the synthetic material segment of the market is expected to grow at a steady rate due to the increasing demand for these materials since it allows obtaining scaffolds with more reproducible and predictable physical behavior.

Key Factors Impacting Market Growth:1.Increasing demand for transplantation of organs2.The rising number of genetic disorders3.Increasing government investments in regenerative medicine research

Key Developments:1. In August 2018, Novartis (Switzerland) received an EU approval for its CAR-T cell therapy.2. In November 2018, Novartis (Switzerland) received EU approval for one-time gene therapy, Luxturna.3. In 2017, Integra LifeSciences (US) introduced its a new product, Integra Dermal Regeneration Template Single layer, that is "very thin", useful for the purpose of dermal repair defects reconstruction.

Regional Outlook:North America, Western Europe, and the Asia Pacific by region are estimated to dominate the regenerative medicine market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for the regenerative medicine market during the forecast period.

The US, Germany, France, UK, Canada, and Spain have been some of the major markets in the region. Asia Pacific is estimated to register one of the highest CAGR for the regenerative medicine market during the forecast period. This region has witnessed strategic investments by global companies to cater to the growing demand in recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for the regenerative medicine market in the region. Other regions including the Middle East, Eastern Europe, and the Rest of the World (South America and Africa) are estimated to be emerging markets for regenerative medicine during the forecast period.

Companies Covered: Zimmer Biomet, Stryker Corporation, Athersys, Medtronic, U.S. Stem Cell, Integra Lifesciences, Organogenesis, Acelity Holdings, CryoLife, and Isto Biologics

Market Segmentation:By Product:1.Gene Therapy2.Cell Therapy3.Small Molecule and Biologic4.Tissue Engineering

By Material:1. Synthetic2. Biologically Derived3. Genetically Engineered4.Pharmaceutical

By Application:1.Oncology2.Cardiovascular3.Musculoskeletal4.Dermatology5.Ophthalmology6.Neurology7.Wound Healing8.Others

By Region:

1.North America a.By Country (US, Canada, Mexico) b.By Product c.By Material d.By Application2.Western Europe: a.By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe) b.By Product c.By Material d.By Application3.Eastern Europe: a.By Country (Russia, Turkey, Rest of Eastern Europe) b.By Product c.By Material d.By Application4.Asia Pacific: a.By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific) b.By Product c.By Material d.By Application5.Middle East: a.By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East) b.By Product c.By Material d.By Application6.Rest of the World a.By Region (South America, Africa) b.By Product c.By Material d.By Application

Reasons to Buy This Report:Market size estimation of the regenerative medicine market on a regional and global basis1.The unique research design for market size estimation and forecastProfiling of major companies operating in the market with key developments2. Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:We provide customization of the study to meet specific requirements:1.By Segment2.By Sub-segment3.By Region/CountryFor more information, contact: sales@quincemarketinsights.com

About US:Quince Market Insights is a global market research and consulting company publishing syndicate studies as well as consulting assignments pertaining to markets that promise high growth opportunities in the strategic future. We are a dedicated team of analysts with a strong base in technical expertise as well as a thorough understanding of the market dynamics.

Contact US:+91-2026992033

+91-2026992034sales@quincemarketinsights.comHadapsar, Pune, India

Pooja Abhyankar An Employee of Quince Market Insights as a Digital Marketing Executive